Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 532 | 348 | 3,000 | 62 | 133 |
| Gross Profit | 532 | 348 | 3,000 | 62 | 133 |
| Operating Expenses | 14,871 | 11,633 | 19,176 | 13,457 | 19,357 |
| Operating Income | -14,339 | -11,285 | -16,176 | -13,395 | -19,224 |
| Other Income | 3,563 | -5 | -6 | -4 | -4 |
| Pre-tax Income | -10,776 | -11,290 | -16,182 | -13,399 | -19,228 |
| Net Income Continuous | -10,776 | -11,290 | -16,182 | -13,399 | -19,228 |
| Net Income | $-10,776 | $-11,290 | $-16,182 | $-13,399 | $-19,228 |
| EPS Basic Total Ops | -4.40 | -5.20 | -9.00 | -7.80 | -10.80 |
| EPS Basic Continuous Ops | -4.25 | -5.22 | -9.06 | -7.86 | -10.78 |
| EPS Diluted Total Ops | -4.40 | -5.20 | -9.00 | -7.80 | -10.80 |
| EPS Diluted Continuous Ops | -4.25 | -5.22 | -9.06 | -7.86 | -10.78 |
| EBITDA(a) | $-14,291 | $-11,237 | $-16,058 | $-13,137 | $-18,754 |